Teza Capital Management’s Globus Medical GMED Stock Holding History

Teza Capital Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-8,712	Closed	-$721K	–	473
2024 Q4	$721K	Buy	+8,712	New	+$687K	0.11%	234
2024 Q2	–	Sell	-5,124	Closed	-$275K	–	646
2024 Q1	$275K	Buy	+5,124	New	+$275K	0.04%	459
2023 Q2	–	Sell	-8,399	Closed	-$476K	–	630
2023 Q1	$476K	Buy	8,399 +3,381	+67%	+$217K	0.1%	282
2022 Q4	$373K	Sell	5,018 -436	-8%	-$29.7K	0.07%	398
2022 Q3	$325K	Buy	5,454 +653	+14%	+$39.3K	0.07%	401
2022 Q2	$270K	Sell	4,801 -1,813	-27%	-$119K	0.1%	328
2022 Q1	$488K	Buy	+6,614	New	+$460K	0.18%	174
2021 Q4	–	Sell	-5,198	Closed	-$398K	–	475
2021 Q3	$398K	Buy	+5,198	New	+$417K	0.19%	165
2017 Q2	–	Sell	-7,185	Closed	-$213K	–	165
2017 Q1	$213K	Buy	+7,185	New	+$196K	0.06%	421

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Teza Capital Management's GMED Position: Q1 2025 in Review

Teza Capital Management sold out of Globus Medical (GMED) in Q1 2025, closing a stake of 8,712 shares — an estimated $721K sold.

Teza Capital Management first reported a position in GMED in Q1 2017 and held it in 9 quarters. The position peaked at $721K in Q4 2024. 514 funds tracked by Wall St. Rank hold GMED as of Q1 2025.

Teza Capital Management reported no remaining Globus Medical position as of Q1 2025 after selling out during the quarter.
Teza Capital Management sold 8,712 Globus Medical shares in Q1 2025, an estimated $721K.
Teza Capital Management first reported a position in Globus Medical in Q1 2017 and held it in 9 quarters.
Teza Capital Management's Globus Medical position peaked at $721K in Q4 2024.
514 funds tracked by Wall St. Rank held Globus Medical as of Q1 2025.

Based on Teza Capital Management's 13F filing for Q1 2025, filed 15 May 2025.